TRHC Chief Scientific Officer Featured in Today’s Geriatric Medicine

Jacques Turgeon, BPharm, PhD, chief scientific officer of Tabula Rasa HealthCare (TRHC) and Veronique Michaud, BPharm, MSc, PhD, chief operation officer of TRHC Precision Pharmacotherapy Research & Development Institute, authored “Medication Monitor: Decreasing Adverse Drug Events” in the January/February issue of Today’s Geriatric Medicine Magazine. Read the full article.

Tabula Rasa HealthCare Retains 99.1% of PACE Clients to Start 2020

Moorestown, NJ, January 13, 2020 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today a client retention rate of 99.1% in the PACE (Programs of All-inclusive Care for the Elderly) market to begin 2020. PACE organizations nationwide rely on TRHC’s PACE division, CareVention HealthCare,™ for technology, services, and consulting to optimize outcomes and maintain regulatory compliance. CareVention’s lead offering for PACE providers is medication... Read More

Tabula Rasa HealthCare Reports Steady Growth in its CareVention HealthCare™ Division

Moorestown, NJ, December 16, 2019 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, continues its market penetration in PACE (Programs of All-inclusive Care for the Elderly). Spurred by TRHC’s CareVention HealthCare™ division, TRHC is providing more than 80% of PACE providers with at least one TRHC PACE solution. TRHC will continue to expand in January 2020, with five new PACE agreements. In addition to these new... Read More

TRHC Presents at Institute for Healthcare Improvement’s National Forum on Quality Improvement in Health Care

Moorestown, NJ, December 11, 2019 – Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC) Senior Director of Learning and Development Lauren E. Steffen, PharmD, BCGP presented at the Institute for Health Improvement’s National Forum on Quality Improvement in Health Care held December 9-11, 2019 in Orlando, FL. TRHC is a healthcare technology company advancing the field of medication safety. The Company is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to... Read More

Tabula Rasa HealthCare Expands into a New Market with Hudson Headwaters Health Network Contract

Moorestown, NJ, December 5, 2019 – Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces a partnership with Hudson Headwaters Health Network, a Queensbury, NY-based nonprofit that operates 19 health centers in northern New York state. Beginning in January 2020, Hudson Headwaters pharmacists will license the MedWise™ technology to identify patients at high risk for medication-related problems and complete Medication Safety Reviews. “TRHC’s partnership with Hudson... Read More

TRHC Vice President of Performance Improvement Featured in Drug Topics

Steve Gilbert, MBA, RPh, BCPS, BCBG, CPHQ, Vice President, Performance Improvement, Tabula Rasa HealthCare was featured in the article “How to Train Staff on New Tech: Tips for Pharmacy Managers”  in the  November 19 issue of Drug Topics.  Access the PDF of Drug Topics.    

Talk To Your Pharmacist Podcast Featuring Jenny Bingham, PharmD, BCACP

In this episode, Jenny Bingham, PharmD, BCACP, discusses telepharmacy services. Dr. Jenny Bingham, is a Clinical Pharmacy Specialist at SinfoniaRx. Throughout her career, she has launched several novel programs aimed to improve the quality of care for patients in a variety of settings. She manages a transition of care program that has led to: reduced readmission rates at 30-, 60-, and 90-days post-discharge; decreased Medicare beneficiary expenditures; and a substantial return-on-investment. Dr. Bingham is committed... Read More

TRHC Position Paper on the Public Health Risk of Strongly Anticholinergic Over-the-Counter Products

Executive Summary In the United States, over-the-counter (OTC) products are consumed by millions of people to self-medicate and, thereby, take an active role in their health care. However, despite public belief, not all OTCs are safe for all people. Over-the-counter products containing drugs with strong anticholinergic properties, such as chlorpheniramine and diphenhydramine, are ubiquitous and can cause myriad side effects, particularly for older Americans. Some anticholinergic side effects can be temporarily severe and disabling. But,... Read More
1 2 3 17